December 24, 2020

Titan Medical Reports Full Compliance with Nasdaq Listing Criteria

TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that on December 24, 2020, the Company received written notification from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has cured the bid price deficiency and has regained full compliance with all applicable criteria for continued listing and trading on The


Leave Comment


Your Name *
Your Email *
Your Website
Comment *